Skip to main content
Top
Published in: BMC Oral Health 1/2023

Open Access 01-12-2023 | Research

Temporal and spatial patterns of recurrence in oral squamous cell carcinoma, a single-center retrospective cohort study in China

Authors: Yannan Wang, Tianru Yang, Chengwen Gan, Kai Wang, Bincan Sun, Mengxue Wang, Feiya Zhu

Published in: BMC Oral Health | Issue 1/2023

Login to get access

Abstract

Background

Oral squamous cell carcinoma (OSCC) is an invasive cancer with a high recurrence rate. Most clinical studies have focused on the prognosis of patients with OSCC, few have investigated the causes and interventions that affect the recurrence. Our study is to explore the temporal and spatial patterns of recurrence in OSCC.

Methods

234 OSCC patients with recurrence in our hospital and 64 OSCC patients with recurrence in TCGA database were included in the study. Log-rank test and Multivariate Cox Regression Analysis were used to determine whether there was a significant difference between each selected demographic or clinical factors and recurrence. The Kaplan–Meier method was used to plot survival curves for each recurrence interval.

Results

The proportion of OSCC patients in clinical and TCGA with early recurrence was 93.6% and 84.4%, respectively. Age, chewing betel nut, previous radiotherapy, histopathological grading of the primary tumor (poorly differentiated), lymph node metastasis and postoperative infection were found to be associated with the timing of recurrence. It was found that tongue cancer has more regional recurrences, while buccal cancer is mostly local and loco-regional recurrences. The earlier the recurrence, the greater the possibility of local-regional recurrence and the worse the prognosis.

Conclusion

Most of recurrent OSCC patients present early recurrence (< 18 months) with poor prognosis, and early recurrence is more prone to local recurrence. Moreover, recurrence site is related with primary site of OSCC.
Literature
1.
go back to reference Bugshan A, Farooq I. Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis. F1000Research, 2020. 9. Bugshan A, Farooq I. Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis. F1000Research, 2020. 9.
2.
go back to reference Budach W, et al. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer. 2006;6(1):28.PubMedPubMedCentral Budach W, et al. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer. 2006;6(1):28.PubMedPubMedCentral
3.
go back to reference Bordoloi D, et al. An investigation on the therapeutic potential of Butein, a Tretrahydroxychalcone Against human oral squamous cell carcinoma. Asian Pac J cancer prevention: APJCP. 2019;20(11):3437. Bordoloi D, et al. An investigation on the therapeutic potential of Butein, a Tretrahydroxychalcone Against human oral squamous cell carcinoma. Asian Pac J cancer prevention: APJCP. 2019;20(11):3437.
4.
go back to reference Ng JH, et al. Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study. Head Neck. 2017;39(2):297–304.PubMed Ng JH, et al. Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study. Head Neck. 2017;39(2):297–304.PubMed
5.
go back to reference Mucke T, et al. Recurrence interval affects survival after local relapse of oral cancer. Oral Oncol. 2009;45(8):687–91.PubMed Mucke T, et al. Recurrence interval affects survival after local relapse of oral cancer. Oral Oncol. 2009;45(8):687–91.PubMed
6.
go back to reference Boysen M, et al. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer. 1992;28(2–3):426–30.PubMed Boysen M, et al. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer. 1992;28(2–3):426–30.PubMed
7.
go back to reference Jones KR, et al. Prognostic factors in the recurrence of stage I and II squamous cell cancer of the oral cavity. Arch Otolaryngol Head Neck Surg. 1992;118(5):483–5.PubMed Jones KR, et al. Prognostic factors in the recurrence of stage I and II squamous cell cancer of the oral cavity. Arch Otolaryngol Head Neck Surg. 1992;118(5):483–5.PubMed
8.
go back to reference Kowalski LP. Results of salvage treatment of the neck in patients with oral cancer. Arch Otolaryngol Head Neck Surg. 2002;128(1):58–62.PubMed Kowalski LP. Results of salvage treatment of the neck in patients with oral cancer. Arch Otolaryngol Head Neck Surg. 2002;128(1):58–62.PubMed
9.
go back to reference Liu SA, et al. Impact of recurrence interval on survival of oral cavity squamous cell carcinoma patients after local relapse. Otolaryngol Head Neck Surg. 2007;136(1):112–8.PubMed Liu SA, et al. Impact of recurrence interval on survival of oral cavity squamous cell carcinoma patients after local relapse. Otolaryngol Head Neck Surg. 2007;136(1):112–8.PubMed
10.
go back to reference Feng Z, et al. Neck recurrence of oral squamous cell carcinoma in unusual sites: retrospective study of 1658 cases. Head Neck. 2016;38(Suppl 1):E680–6.PubMed Feng Z, et al. Neck recurrence of oral squamous cell carcinoma in unusual sites: retrospective study of 1658 cases. Head Neck. 2016;38(Suppl 1):E680–6.PubMed
11.
go back to reference Cooney TR, Poulsen MG. Is routine follow-up useful after combined-modality therapy for advanced head and neck cancer? Arch Otolaryngol Head Neck Surg. 1999;125(4):379–82.PubMed Cooney TR, Poulsen MG. Is routine follow-up useful after combined-modality therapy for advanced head and neck cancer? Arch Otolaryngol Head Neck Surg. 1999;125(4):379–82.PubMed
12.
go back to reference Flynn CJ, et al. The Value of Periodic follow-up in the detection of Recurrences after Radical Treatment in locally Advanced Head and Neck Cancer. Clin Oncol. 2010;22(10):868–73. Flynn CJ, et al. The Value of Periodic follow-up in the detection of Recurrences after Radical Treatment in locally Advanced Head and Neck Cancer. Clin Oncol. 2010;22(10):868–73.
13.
go back to reference Brands MT, et al. Time patterns of recurrence and second primary tumors in a large cohort of patients treated for oral cavity cancer. Cancer Med. 2019;8(12):5810–9.PubMedPubMedCentral Brands MT, et al. Time patterns of recurrence and second primary tumors in a large cohort of patients treated for oral cavity cancer. Cancer Med. 2019;8(12):5810–9.PubMedPubMedCentral
14.
go back to reference Dilkes MG, et al. Treatment of head and neck cancer with photodynamic therapy: results after one year. J Laryngol Otol. 1995;109(11):1072–6.PubMed Dilkes MG, et al. Treatment of head and neck cancer with photodynamic therapy: results after one year. J Laryngol Otol. 1995;109(11):1072–6.PubMed
15.
go back to reference Lore JM Jr. Early diagnosis and treatment of head and neck cancer. CA Cancer J Clin. 1995;45(6):325–7.PubMed Lore JM Jr. Early diagnosis and treatment of head and neck cancer. CA Cancer J Clin. 1995;45(6):325–7.PubMed
16.
go back to reference Shah JP, Lydiatt W. Treatment of cancer of the head and neck. CA Cancer J Clin. 1995;45(6):352–68.PubMed Shah JP, Lydiatt W. Treatment of cancer of the head and neck. CA Cancer J Clin. 1995;45(6):352–68.PubMed
17.
go back to reference Wang W, et al. A study of epidemiologic and recurrence factors of oral cancer. J Oral Maxillofac Surg. 2012;70(9):2205–10.PubMed Wang W, et al. A study of epidemiologic and recurrence factors of oral cancer. J Oral Maxillofac Surg. 2012;70(9):2205–10.PubMed
18.
go back to reference Weckx A, et al. Time to recurrence and patient survival in recurrent oral squamous cell carcinoma. Oral Oncol. 2019;94:8–13.PubMed Weckx A, et al. Time to recurrence and patient survival in recurrent oral squamous cell carcinoma. Oral Oncol. 2019;94:8–13.PubMed
19.
go back to reference Safi AF, et al. Analysis of clinicopathological risk factors for locoregional recurrence of oral squamous cell carcinoma - retrospective analysis of 517 patients. J Craniomaxillofac Surg. 2017;45(10):1749–53.PubMed Safi AF, et al. Analysis of clinicopathological risk factors for locoregional recurrence of oral squamous cell carcinoma - retrospective analysis of 517 patients. J Craniomaxillofac Surg. 2017;45(10):1749–53.PubMed
20.
go back to reference Hosal AS, et al. Selective neck dissection in the management of the clinically node-negative neck. Laryngoscope. 2000;110(12):2037–40.PubMed Hosal AS, et al. Selective neck dissection in the management of the clinically node-negative neck. Laryngoscope. 2000;110(12):2037–40.PubMed
21.
go back to reference Hamoir M, et al. Salvage surgery in recurrent head and neck squamous cell carcinoma: oncologic outcome and predictors of disease free survival. Oral Oncol. 2017;67:1–9.PubMed Hamoir M, et al. Salvage surgery in recurrent head and neck squamous cell carcinoma: oncologic outcome and predictors of disease free survival. Oral Oncol. 2017;67:1–9.PubMed
22.
go back to reference D’Cruz AK, et al. Elective versus therapeutic Neck dissection in node-negative oral Cancer. N Engl J Med. 2015;373(6):521–9.PubMed D’Cruz AK, et al. Elective versus therapeutic Neck dissection in node-negative oral Cancer. N Engl J Med. 2015;373(6):521–9.PubMed
23.
go back to reference Spoerl S, et al. Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study. Clin Oral Invest. 2021;25(4):1705–13. Spoerl S, et al. Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study. Clin Oral Invest. 2021;25(4):1705–13.
24.
go back to reference Terabe T, et al. Expression of autophagy-related markers at the surgical margin of oral squamous cell carcinoma correlates with poor prognosis and tumor recurrence. Hum Pathol. 2018;73:156–63.PubMed Terabe T, et al. Expression of autophagy-related markers at the surgical margin of oral squamous cell carcinoma correlates with poor prognosis and tumor recurrence. Hum Pathol. 2018;73:156–63.PubMed
25.
go back to reference Kademani D, et al. Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade. J oral maxillofacial surgery: official J Am Association Oral Maxillofacial Surg. 2005;63(11):1599–605. Kademani D, et al. Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade. J oral maxillofacial surgery: official J Am Association Oral Maxillofacial Surg. 2005;63(11):1599–605.
26.
go back to reference Brandwein-Gensler M, et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol. 2005;29(2):167–78.PubMed Brandwein-Gensler M, et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol. 2005;29(2):167–78.PubMed
27.
go back to reference Arduino PG, et al. Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases. J Oral Maxillofac Surg. 2008;66(8):1570–9.PubMed Arduino PG, et al. Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases. J Oral Maxillofac Surg. 2008;66(8):1570–9.PubMed
28.
go back to reference Yanamoto S, et al. Clinicopathological risk factors for local recurrence in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2012;41(10):1195–200.PubMed Yanamoto S, et al. Clinicopathological risk factors for local recurrence in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2012;41(10):1195–200.PubMed
29.
go back to reference [Guideline on pathological diagnosis of oral and oropharyngeal squamous cell carcinoma] Zhonghua Kou Qiang Yi Xue Za Zhi, 2020. 55(3): p. 145–152. [Guideline on pathological diagnosis of oral and oropharyngeal squamous cell carcinoma] Zhonghua Kou Qiang Yi Xue Za Zhi, 2020. 55(3): p. 145–152.
30.
go back to reference Kernohan MD, et al. Predicting the prognosis of oral squamous cell carcinoma after first recurrence. Archives of Otolaryngology–Head & Neck Surgery. 2010;136(12):1235–9. Kernohan MD, et al. Predicting the prognosis of oral squamous cell carcinoma after first recurrence. Archives of Otolaryngology–Head & Neck Surgery. 2010;136(12):1235–9.
31.
go back to reference Ermer M, et al. Recurrence rate and shift in histopathological differentiation of oral squamous cell carcinoma–a long-term retrospective study over a period of 13.5 years. J Cranio-Maxillofacial Surg. 2015;43(7):1309–13. Ermer M, et al. Recurrence rate and shift in histopathological differentiation of oral squamous cell carcinoma–a long-term retrospective study over a period of 13.5 years. J Cranio-Maxillofacial Surg. 2015;43(7):1309–13.
32.
go back to reference Raj LS, Boaz MK, Natarajan S. Prognostic significance of Lymph Node Pattern in oral squamous cell carcinoma (OSCC). J Clin Diagn research: JCDR. 2014;8(1):232–5. Raj LS, Boaz MK, Natarajan S. Prognostic significance of Lymph Node Pattern in oral squamous cell carcinoma (OSCC). J Clin Diagn research: JCDR. 2014;8(1):232–5.
33.
go back to reference Olasz L, et al. Induction chemotherapy response and recurrence rates in correlation with N0 or N + stage in oral squamous cell cancer (OSCC). Cancer Metastasis Rev. 2010;29(4):607–11.PubMed Olasz L, et al. Induction chemotherapy response and recurrence rates in correlation with N0 or N + stage in oral squamous cell cancer (OSCC). Cancer Metastasis Rev. 2010;29(4):607–11.PubMed
34.
go back to reference Rogers SN, et al. Survival following primary surgery for oral cancer. Oral Oncol. 2009;45(3):201–11.PubMed Rogers SN, et al. Survival following primary surgery for oral cancer. Oral Oncol. 2009;45(3):201–11.PubMed
35.
go back to reference Vazquez-Mahia I, et al. Predictors for tumor recurrence after primary definitive surgery for oral cancer. J Oral Maxillofac Surg. 2012;70(7):1724–32.PubMed Vazquez-Mahia I, et al. Predictors for tumor recurrence after primary definitive surgery for oral cancer. J Oral Maxillofac Surg. 2012;70(7):1724–32.PubMed
36.
go back to reference Stathopoulos P, Smith WP. Analysis of Survival Rates following primary surgery of 178 consecutive patients with oral Cancer in a large District General Hospital. J Maxillofac Oral Surg. 2017;16(2):158–63.PubMed Stathopoulos P, Smith WP. Analysis of Survival Rates following primary surgery of 178 consecutive patients with oral Cancer in a large District General Hospital. J Maxillofac Oral Surg. 2017;16(2):158–63.PubMed
37.
go back to reference Kernohan MD, et al. Predicting the prognosis of oral squamous cell carcinoma after first recurrence. Arch Otolaryngol Head Neck Surg. 2010;136(12):1235–9.PubMed Kernohan MD, et al. Predicting the prognosis of oral squamous cell carcinoma after first recurrence. Arch Otolaryngol Head Neck Surg. 2010;136(12):1235–9.PubMed
38.
go back to reference Guo T, Rettig E, Fakhry C. Understanding the impact of survival and human papillomavirus tumor status on timing of recurrence in oropharyngeal squamous cell carcinoma. Oral Oncol. 2016;52:97–103.PubMed Guo T, Rettig E, Fakhry C. Understanding the impact of survival and human papillomavirus tumor status on timing of recurrence in oropharyngeal squamous cell carcinoma. Oral Oncol. 2016;52:97–103.PubMed
39.
go back to reference Chamoli A, et al. Overview of oral cavity squamous cell carcinoma: risk factors, mechanisms, and diagnostics. Oral Oncol. 2021;121:105451.PubMed Chamoli A, et al. Overview of oral cavity squamous cell carcinoma: risk factors, mechanisms, and diagnostics. Oral Oncol. 2021;121:105451.PubMed
40.
go back to reference Fukumoto C et al. Surveillance for Patients with Oral Squamous Cell Carcinoma after Complete Surgical Resection as Primary Treatment: A Single-Center Retrospective Cohort Study Cancers (Basel), 2021. 13(22). Fukumoto C et al. Surveillance for Patients with Oral Squamous Cell Carcinoma after Complete Surgical Resection as Primary Treatment: A Single-Center Retrospective Cohort Study Cancers (Basel), 2021. 13(22).
41.
go back to reference Paleri V, et al. Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130(S2):S161–s169.PubMedPubMedCentral Paleri V, et al. Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130(S2):S161–s169.PubMedPubMedCentral
42.
go back to reference Chen SW, et al. Trends in clinical features and survival of oral cavity cancer: fifty years of experience with 3,362 consecutive cases from a single institution. Cancer Manag Res. 2018;10:4523–35.PubMedPubMedCentral Chen SW, et al. Trends in clinical features and survival of oral cavity cancer: fifty years of experience with 3,362 consecutive cases from a single institution. Cancer Manag Res. 2018;10:4523–35.PubMedPubMedCentral
43.
go back to reference Caudell JJ, et al. NCCN Guidelines® insights: Head and Neck Cancers, Version 1.2022. J Natl Compr Canc Netw. 2022;20(3):224–34.PubMed Caudell JJ, et al. NCCN Guidelines® insights: Head and Neck Cancers, Version 1.2022. J Natl Compr Canc Netw. 2022;20(3):224–34.PubMed
44.
go back to reference Siraj F, et al. Radiation-induced Leiomyosarcoma of the oral cavity: a rare occurrence detected on 18F-FDG PET/CT. World J Nucl Med. 2016;15(3):212–4.PubMedPubMedCentral Siraj F, et al. Radiation-induced Leiomyosarcoma of the oral cavity: a rare occurrence detected on 18F-FDG PET/CT. World J Nucl Med. 2016;15(3):212–4.PubMedPubMedCentral
45.
go back to reference Ryu IS, et al. Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by 18F-FDG PET/CT in squamous cell carcinoma of the oral cavity. Eur J Nucl Med Mol Imaging. 2014;41(3):452–61.PubMed Ryu IS, et al. Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by 18F-FDG PET/CT in squamous cell carcinoma of the oral cavity. Eur J Nucl Med Mol Imaging. 2014;41(3):452–61.PubMed
46.
go back to reference Hasmat S, et al. Multifocal perineural invasion is a better prognosticator than depth of invasion in oral squamous cell carcinoma. Head Neck. 2019;41(11):3992–9.PubMed Hasmat S, et al. Multifocal perineural invasion is a better prognosticator than depth of invasion in oral squamous cell carcinoma. Head Neck. 2019;41(11):3992–9.PubMed
47.
go back to reference Recht A, et al. The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radiation Oncology*Biology*Physics. 1988;14(1):3–10. Recht A, et al. The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radiation Oncology*Biology*Physics. 1988;14(1):3–10.
48.
go back to reference Oh JL, et al. The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: how young is “young”? Int J Radiation Oncology*Biology*Physics. 2006;65(5):1345–52. Oh JL, et al. The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: how young is “young”? Int J Radiation Oncology*Biology*Physics. 2006;65(5):1345–52.
49.
go back to reference Schack A, et al. Perioperative Use of nonsteroidal anti-inflammatory drugs decreases the risk of recurrence of Cancer after Colorectal Resection: a Cohort Study based on prospective data. Ann Surg Oncol. 2019;26(12):3826–37.PubMed Schack A, et al. Perioperative Use of nonsteroidal anti-inflammatory drugs decreases the risk of recurrence of Cancer after Colorectal Resection: a Cohort Study based on prospective data. Ann Surg Oncol. 2019;26(12):3826–37.PubMed
50.
go back to reference Ruan D-y, et al. Impact of postoperative intra-abdominal infection on tumor recurrence and survival in hepatocellular carcinoma after curative liver resection. J Clin Oncol. 2014;32(3suppl):374–4. Ruan D-y, et al. Impact of postoperative intra-abdominal infection on tumor recurrence and survival in hepatocellular carcinoma after curative liver resection. J Clin Oncol. 2014;32(3suppl):374–4.
51.
go back to reference Chang W-C, et al. Lymph node density as a prognostic predictor in patients with betel nut-related oral squamous cell carcinoma. Clin Oral Invest. 2018;22(3):1513–21. Chang W-C, et al. Lymph node density as a prognostic predictor in patients with betel nut-related oral squamous cell carcinoma. Clin Oral Invest. 2018;22(3):1513–21.
52.
go back to reference Chiang C-P, et al. Hamsters chewing betel quid or areca nut directly show a decrease in body weight and survival rates with concomitant epithelial hyperplasia of cheek pouch. Oral Oncol. 2004;40(7):720–7.PubMed Chiang C-P, et al. Hamsters chewing betel quid or areca nut directly show a decrease in body weight and survival rates with concomitant epithelial hyperplasia of cheek pouch. Oral Oncol. 2004;40(7):720–7.PubMed
53.
go back to reference Lindenblatt RdCR, et al. Oral squamous cell carcinoma grading systems–analysis of the best survival predictor. J oral Pathol Med. 2012;41(1):34–9.PubMed Lindenblatt RdCR, et al. Oral squamous cell carcinoma grading systems–analysis of the best survival predictor. J oral Pathol Med. 2012;41(1):34–9.PubMed
54.
go back to reference Liu C-H, et al. Patterns of recurrence and second primary tumors in oral squamous cell carcinoma treated with surgery alone. Kaohsiung J Med Sci. 2013;29(10):554–9.PubMed Liu C-H, et al. Patterns of recurrence and second primary tumors in oral squamous cell carcinoma treated with surgery alone. Kaohsiung J Med Sci. 2013;29(10):554–9.PubMed
55.
go back to reference Wang B, et al. The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases. Chin J cancer. 2013;32(11):614.PubMedPubMedCentral Wang B, et al. The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases. Chin J cancer. 2013;32(11):614.PubMedPubMedCentral
56.
go back to reference Feng Z, et al. Neck recurrence of oral squamous cell carcinoma in unusual sites: retrospective study of 1658 cases. Head Neck. 2016;38(S1):E680–6.PubMed Feng Z, et al. Neck recurrence of oral squamous cell carcinoma in unusual sites: retrospective study of 1658 cases. Head Neck. 2016;38(S1):E680–6.PubMed
57.
go back to reference Fan K-H, et al. Treatment results of postoperative radiotherapy on squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk factors results in higher recurrence rates. Int J Radiation Oncology* Biology* Phys. 2010;77(4):1024–9. Fan K-H, et al. Treatment results of postoperative radiotherapy on squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk factors results in higher recurrence rates. Int J Radiation Oncology* Biology* Phys. 2010;77(4):1024–9.
58.
go back to reference Ghantous Y, Bahouth Z, Abu El-Naaj I. Clinical and genetic signatures of local recurrence in oral squamous cell carcinoma. Arch Oral Biol. 2018;95:141–8.PubMed Ghantous Y, Bahouth Z, Abu El-Naaj I. Clinical and genetic signatures of local recurrence in oral squamous cell carcinoma. Arch Oral Biol. 2018;95:141–8.PubMed
59.
go back to reference Mücke T, et al. Recurrence interval affects survival after local relapse of oral cancer. Oral Oncol. 2009;45(8):687–91.PubMed Mücke T, et al. Recurrence interval affects survival after local relapse of oral cancer. Oral Oncol. 2009;45(8):687–91.PubMed
60.
go back to reference Troeltzsch M, et al. What factors are associated with regional recurrence after operative treatment of oral squamous cell carcinoma? J Oral Maxillofac Surg. 2018;76(12):2650–9.PubMed Troeltzsch M, et al. What factors are associated with regional recurrence after operative treatment of oral squamous cell carcinoma? J Oral Maxillofac Surg. 2018;76(12):2650–9.PubMed
61.
go back to reference De Cicco C, et al. Lymphatic mapping to tailor selective lymphadenectomy in cN0 tongue carcinoma: beyond the sentinel node concept. Eur J Nucl Med Mol Imaging. 2006;33(8):900–5.PubMed De Cicco C, et al. Lymphatic mapping to tailor selective lymphadenectomy in cN0 tongue carcinoma: beyond the sentinel node concept. Eur J Nucl Med Mol Imaging. 2006;33(8):900–5.PubMed
62.
go back to reference Werner JA. [The lymph vessel system of the mouth cavity and pharynx]. Laryngorhinootologie. 1995;74(10):622–8.PubMed Werner JA. [The lymph vessel system of the mouth cavity and pharynx]. Laryngorhinootologie. 1995;74(10):622–8.PubMed
63.
go back to reference Caldeira PC, et al. Tumor depth of invasion and prognosis of early-stage oral squamous cell carcinoma: a meta-analysis. Oral Dis. 2020;26(7):1357–65.PubMed Caldeira PC, et al. Tumor depth of invasion and prognosis of early-stage oral squamous cell carcinoma: a meta-analysis. Oral Dis. 2020;26(7):1357–65.PubMed
64.
go back to reference Liu T, et al. Treatment for oral squamous cell carcinoma: impact of surgeon volume on survival. Oral Oncol. 2019;96:60–5.PubMed Liu T, et al. Treatment for oral squamous cell carcinoma: impact of surgeon volume on survival. Oral Oncol. 2019;96:60–5.PubMed
Metadata
Title
Temporal and spatial patterns of recurrence in oral squamous cell carcinoma, a single-center retrospective cohort study in China
Authors
Yannan Wang
Tianru Yang
Chengwen Gan
Kai Wang
Bincan Sun
Mengxue Wang
Feiya Zhu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2023
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-023-03204-7

Other articles of this Issue 1/2023

BMC Oral Health 1/2023 Go to the issue